Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

Tetra Bio-Pharma Announces Outcome of its Meeting with its Scientific and Clinical Advisory Board $TBP.ca

Posted by AGORACOM-JC at 1:20 PM on Wednesday, November 2nd, 2016

Tbp_large

  • Held its Scientific and Clinical Advisory Board (“CAB”) meeting on October 29th
  • CAB reviewed the development program of PPP’s inhalation cannabis product PPP001
  • Medical marijuana product that the company is developing as a prescription controlled drug for inhalation using a fully assembled titanium pipe

OTTAWA, ONTARIO–(Nov. 2, 2016) – Tetra Bio-Pharma Inc. (“TetraBio” or the “Company“) (CSE:TBP) through its subsidiary, PhytoPain Pharma Inc. (“PPP“), is pleased to announce that it held its Scientific and Clinical Advisory Board (“CAB“) meeting on October 29th. The CAB reviewed the development program of PPP’s inhalation cannabis product PPP001. PPP001 is a medical marijuana product that the company is developing as a prescription controlled drug for inhalation using a fully assembled titanium pipe.

The Board, which is comprised of experts in clinical research, pain management as well as cancer, and neurological product drug development (ref: news release August 26, 2016), met to review and discuss the development program to date, the study design of the Phase I trial and the overall clinical development plan of PPP001. This included the exclusion and inclusion criteria of the proposed Phase I trial, the Phase 1a and 1b dosing scheme, and the pharmacokinetic and pharmacodynamic assessments. The CAB also examined the clinical rationale for the selection of the delta-9-tetrahydrocannibinol (THC) and Cannabidiol (CBD) dose levels for use in PPP001.

The CAB also reviewed the salient elements of future PPP’s Phase II and III clinical trials for the development of PPP001 in various medical conditions, including the use of medical marijuana as a second or third line therapy for cancer and HIV patients with uncontrolled pain. The CAB reports directly to the Board of Directors of the Company and will be submitting a report on the outcome of the CAB meeting in the near future.

Currently, there is only limited safety or efficacy information, if any, derived from well-controlled clinical trials available to physicians to adequately assess the benefits and risks of prescribing medical marijuana. Dr. Luc Vachon, President of the CAB commented: ²the members of the CAB are very pleased and excited to be participating in a full pharmaceutical approach on the development of medical marijuana as a prescription drug. The members expressed that the clinical development plan used by PPP – supported by a formal regulatory path – will help generate the type of clinical information required by physicians.²

“This team of scientific and clinical experts provided us with excellent guidance on the development program. We are pleased to recommend to the Board of Directors that PPP is ready to submit the Clinical Trial Application (CTA) for the conduct of its Phase I trial in healthy human volunteers,” stated Dr. Chamberland, Chief Scientific Officer and Regulatory Affairs.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
André Rancourt
Chief Executive Officer
(613) 421-8402

Tetra Bio-Pharma Inc.
Ryan Brown
VP Business Development and Communications
(613) 421-8402

Tetra Bio-Pharma Inc.
André Audet
Executive Chairman
(613) 421-8402

 

Tags: , ,
Posted in Medical Marijuana Stocks, Tetra Bio-Pharma Inc., Tetra Brio-Pharma Inc. | Comments Off on Tetra Bio-Pharma Announces Outcome of its Meeting with its Scientific and Clinical Advisory Board $TBP.ca

Durango Completes Sampling Program On Its Limestone Properties $DGO.ca

Posted by AGORACOM-JC at 9:02 AM on Tuesday, November 1st, 2016

Logo

  • Completed site visits to its wholly owned limestone properties located on the northwest coast of British Columbia
  • Total of twenty-four samples were taken on the properties and submitted for assay

Vancouver, BC / November 1, 2016 – Durango Resources Inc. (TSX.V-DGO), (the “Company” or “Durango”) reports that further to its news release of October 25, 2016, it has completed site visits to its wholly owned limestone properties located on the northwest coast of British Columbia.

A small exploration crew evaluated the site logistics and completed a small sampling program on the Smith Island and Mayner’s Fortune properties. The crew accessed the Mayner’s Fortune property by helicopter and nearby logging roads and and accessed the Smith Island property by helicopter. A total of twenty-four samples were taken on the properties and submitted for assay. The results will be provided as they become available.

Marcy Kiesman, CEO comments: “Durango originally obtained the limestone properties in northwestern BC to coincide with the potential LNG facilities which will require limestone for cement and aggregate. However, depending on the grade and quality of limestone, it has many other uses, including as a livestock feed additive and an additive to breads, cereals, toothpaste, papers, plastics, glass, paint, tiles, medicines and cosmetics. We look forward to advancing this compelling opportunity to bring value to our shareholders.”

The past producing Smith Island claims are located 6km southwest of Lelu Island, the proposed site of a pending $36 billion LNG facility that recently received conditional approval of the federal government. The Mayner’s Fortune claims are located approximately 7.5km southwest of Terrace, B.C., along the CN rail line between Terrace and Kitimat, B.C., where the proposed Royal Dutch Shell Consortium $40 billion LNG facility awaits a final investment decision.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and certain lithium properties near the Whabouchi project, the Buckshot graphite property near the Miller Mine in Quebec, the Dianna Lake silver project in northern Saskatchewan, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario, as well as three sets of claims in the Labrador nickel corridor.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: [email protected]

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including commencement and completion of the LNG projects, obtaining final government, industry and other approvals of such projects, future exploration or project development programs on the limestone properties and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , ,
Posted in Durango Resources | Comments Off on Durango Completes Sampling Program On Its Limestone Properties $DGO.ca

American Creek Reports on Treaty Creek JV Drill Results – 338m of 0.70 g/t gold $AMK.ca

Posted by AGORACOM-JC at 9:06 AM on Friday, October 28th, 2016
Hublogolarge2_copy
  • Hole CB-16-03 returned 0.526 g/t gold over 629.7 meters
  • Significantly, included within this wide 629.7 meter interval is 338 meters of 0.70 g/t gold
  • Also included 54 meters (from 88 to 142 meters) of 1.117 g/t gold and 122 meters (from 304 to 426 meters) of 0.965 g/t gold
American Creek Reports on Treaty Creek JV Drill Results — Wide Intersections of Gold Mineralization in CB-16-03

CARDSTON, ALBERTA–(Oct. 28, 2016) – American Creek Resources Ltd. (TSX VENTURE:AMK) (“American Creek”) is pleased to report that Tudor Gold Corp. (“Tudor”) has released the assays for the remainder of hole CB-16-03, a newly discovered gold zone at the Treaty Creek JV Project located in BC’s “Golden Triangle” immediately north of Seabridge Gold’s KSM project and in the same region as Pretivm’s Brucejack project.

Hole CB-16-03 returned 0.526 g/t gold over 629.7 meters. Significantly, included within this wide 629.7 meter interval is 338 meters of 0.70 g/t gold (from 88 meters to 426 meters) which included 54 meters (from 88 to 142 meters) of 1.117 g/t gold and 122 meters (from 304 to 426 meters) of 0.965 g/t gold. The drill hole terminated at 717.7 meters in mineralization with the final 13.7 meters averaging 0.315 g/t Au.

The 338 meter intersection of near surface 0.70 g/t gold in hole CB-16-03 represents the best mineralized intersection discovered to date at Treaty Creek. The hole is located approximately 870 meters northeast of drill hole CB-09-14, which returned 241 meters averaging 0.80 g/t gold.

Walter Storm, CEO and President of Tudor Gold stated: “The complete results from CB-16-03 confirm our belief that Treaty Creek holds the potential to host significant gold mineralization and validates our exploration model. To date, we have successfully hit gold mineralization down to 717 meters downhole and have encountered nearer to surface gold mineralization like the 1.12 grams gold per tonne over 54 meters starting at 88 meters downhole, which opens up the targeted area.”

Drill Hole CB-16-03 was drilled at an azimuth of 292º with an inclination of -73º and was collared approximately 550 meters northeast of the nearest of the Copper Belle zone drill holes CB-09-11 which carried 229m of 0.52 g/t gold from 40m to 270 m, CB-09-10 which carried 212m of 0.47 g/t gold from 119m to 331 m and CB-09-06 which carried 65.3m of 0.84 g/t gold. The new gold intercept encountered in CB-16-03 may represent a new mineralized zone or could possibly be an extension of the previously known Copper Belle Zone. Further work will be required in order to investigate the continuity between these areas. The casing has been left in place so the hole may be re-entered and extended if desired. All intervals are down hole widths as there is not enough information to calculate true widths of the mineralization encountered in any of the holes.

Hole CB-16-03 was drilled to test a geophysical anomaly identified on a preliminary Magnetotelluric (MT) profile along Seabridge Gold’s proposed tunnel route and further defined based on a survey carried out by Simcoe Geoscience Ltd. earlier in the season. Tudor awaits the final results of the MT survey.

Tudor previously released partial assay results from hole CB-16-03 (316 to 717.7 meters downhole), along with complete assays for drill holes CB-16-01 and CB-16-02 in Tudor’s news release dated October 11, 2016. In total, eight holes were drilled on the property for a total of 3,765 meters during the 2016 field season. Assay results are pending for the last five holes.

The Treaty Creek Project is a joint venture between Tudor, American Creek and Teuton Resources Corp. (“Teuton”). Tudor is the operator and holds a 60% interest with both American Creek and Teuton each holding respective 20% fully carried interests in the property (carried until a production notice is given).

James Hutter, P.Geo., is the Qualified Person as defined by National Instrument 43-101 for the 2016 Treaty Creek Project and the results reported by Tudor.

Darren Blaney, American Creek CEO stated: “We are very excited about results from the first three 2016 holes on Treaty Creek. Collectively they’ve extended the known mineralization at Copper Belle, found a new gold zone, and extended gold intervals to depth. The first three holes are all in close proximity to the ‘discovery contact’ discussed in the 2014 Kyba/Nelson BC Geological Survey report, to the Sulphurets thrust fault, and to clastic sequencing (Turbidites) found on Treaty Creek. According to the report, these three things in combination increase the chances of ‘being in the right neighborhood of BC’s next big deposit.’ We believe the results thus far at Treaty Creek are the beginning of that discovery process.”

American Creek is a Canadian mineral exploration company focused on the acquisition, exploration and development of gold and silver properties within the Province of British Columbia, Canada.

In addition to the Treaty Creek project, the Corporation holds interests in the following “Golden Triangle” properties:

Electrum property

The Electrum property is located approximately 45 km north of Stewart between Pretivm’s Brucejack gold deposit located 25 km to the north and the past producing Premier gold mine 20 km to the south. The Electrum shares similar geology to both the Brucejack and the Premier. The project is a JV between operator Tudor (60%) and American Creek (40%).

Tudor recently concluded a diamond drilling and blast trenching program. Initial trenching results reported by Tudor on Sept 12, 2016 included silver grades up to 30,200 g/t within the New Blast vein system. Further results from the drilling and trenching are pending.

Dunwell mine

American Creek recently acquired a property package which included the historic Dunwell mine (see October 3 news release). The Dunwell mine produced 45,657 tonnes averaging 6.63 g/t gold, 223.91 g/t silver, 1.83 per cent lead, 4.01 per cent zinc and 0.056 per cent copper. Recent drilling has shown potential to develop more reserves.

The 850 hectare property is located 8km north of the town of Stewart and intersects paved Highway 37A. It is adjacent to American Creek’s Silvershot property. The principal Dunwell workings are about 2km east of the highway and are accessible by 4×4 vehicle with travel to the remaining portions of the property by foot. Due to the property being located at low elevation, exploration can take place almost year-round.

Information relating to the Corporation is available on its website at www.americancreek.com.

Cautionary statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially.

All statements including, without limitation, statements relating to the potential mineralization and geological merits of the Treaty Creek property and other future plans, objectives or expectations of the Company are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s plans or expectations include risks relating to the actual results of current exploration activities, fluctuating gold prices, possibility of equipment breakdowns and delays, exploration cost overruns, availability of capital and financing, general economic, market or business conditions, regulatory changes, timeliness of government or regulatory approvals and other risks detailed herein and from time to time in the filings made by the Company with securities regulators. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

American Creek Resources Ltd.
Kelvin Burton
403 752-4040
[email protected]
www.americancreek.com

Tags: , , , , , , ,
Posted in All Recent Posts, American Creek Resources Ltd. | Comments Off on American Creek Reports on Treaty Creek JV Drill Results – 338m of 0.70 g/t gold $AMK.ca

VGambling Appoints Director $GMBL

Posted by AGORACOM-JC at 2:12 PM on Thursday, October 27th, 2016

Vgabmlinglarge_copy

  • Recently appointed Mr. David George Atmore Watt, FCCA as a Member of the Board of Directors of the Company
  • Mr. Watt, FCCA, age 58, is a Fellow of the Chartered Association of Certified Accountants of the UK. Mr. Watt is a Chartered Certified Accountant and a Member of the Institute of Chartered Accountants of the Eastern Caribbean with more than 25 years of finance, accounting and senior management experience

ST. MARY’S, ANTIGUA–(Oct 27, 2016) – VGambling Inc. (OTCQB: GMBL) (or the “Company”), a next generation online gambling company specifically focused on eSports, has recently appointed Mr. David George Atmore Watt, FCCA as a Member of the Board of Directors of the Company.

“We are honoured to have Mr. Watt join our Board of Directors,” said Grant Johnson, Chairman of VGambling. “We believe that Mr. Watt’s leadership and financial expertise will enable him to contribute significant managerial and strategic oversight skills to the Company.”

Biography of Mr. Watt, Director

Mr. Watt, FCCA, age 58, is a Fellow of the Chartered Association of Certified Accountants of the UK. Mr. Watt is a Chartered Certified Accountant and a Member of the Institute of Chartered Accountants of the Eastern Caribbean with more than 25 years of finance, accounting and senior management experience. Most recently, Mr. Watt was Financial Controller for the Blue Waters Hotel and Caribbean Developments (ANU) Ltd., both in Antigua. Previously, Mr. Watt was a Partner with the accounting firm Derrick & Watt in Antigua. Prior, Mr. Watt was an Accountant with South Bank Glass Co. Ltd, Input Typesetting Limited, and Cable & Wireless Plc all in London, UK. Mr. Watt is a graduate of South Bank Polytechnic in London, UK.

On October 26, 2016, Mr. Chul Woong Lim resigned from his position as a director of the Board of Directors the Company. The resignation was effective immediately.

About VGambling Inc.

VGambling Inc. is a next generation online gambling company specifically focused on eSports. VGambling intends to offer wagering on eSports events on a fully licensed, regulated and secured platform to the global eSports audience, excluding the United States. In addition, VGambling intends to offer users from around the world the ability to participate in multi-player video games tournaments online for cash prizes. VGambling is led by a team of industry and technical experts from the online gambling and video game industries, e-Sports, marketing, legal and financial professionals. The Company maintains offices in St. Mary’s, Antigua and Barbuda. VGambling is currently developing several play money websites and their real money wagering website. VGambling common stock is listed on the OTCQB under the symbol GMBL. For more information, please see www.vgambling.net

Contact:
Grant Johnson
Chief Executive Officer
Tel. +1-905-580-2978
[email protected]

Tags: , , , , , ,
Posted in All Recent Posts, eSports Investing, VGambling Inc. | Comments Off on VGambling Appoints Director $GMBL

Nevada Energy Metals Appoints Alan Morris as Geology Advisor $BFF.ca

Posted by AGORACOM-JC at 9:06 AM on Wednesday, October 26th, 2016

Bff_hub-2_copy

  • Alan Morris, Qualified Person for the Company’s lithium projects in Nevada has been appointed to the Advisory Board of Nevada Energy Metals. He will serve as the company’s Geology Advisor
  • Owner of Ruby Mountain GIS, founded in 2003 and specializing in property and project evaluations and acquisitions
  • Over 37 years of experience in the minerals industry

October 26, 2016 / Vancouver, British Columbia- Nevada Energy Metals Inc. “the Company”, TSX-V: BFF (OTCQB: SSMLF) (Frankfurt: A2AFBV) is pleased to report that Alan Morris, the Qualified Person for the Company’s lithium projects in Nevada has been appointed to the Advisory Board of Nevada Energy Metals. He will serve as the company’s Geology Advisor.

Mr. Morris is owner of Ruby Mountain GIS, founded in 2003 and specializing in property and project evaluations and acquisitions. He has over 37 years of experience in the minerals industry, exploring for precious and base metals, uranium, lithium and other minerals in a variety of geologic environments, with an emphasis in the western U.S., particularly Nevada, Alaska, and Yukon, Canada. His experience with lithium brine deposits in western Nevada dates from 2010. He has held exploration geologist positions at various companies during his career, including Gulf Mineral Resources Corp., Fischer Watt Mining Company, Barrick Gold Exploration, Placer Dome Corp., Agnico-Eagle Mines Ltd., U.S. Gold Corp. (McEwen Mining), and Kinross Gold Corp. Mr. Morris has supervised numerous generative and drilling projects including planning, budgeting, permitting, contract administration, reclamation, and reporting. Mr. Morris is a Certified Professional Geologist with the American Institute of Professional Geologists (AIPG), a Licensed Geologist in the state of Utah, USA, and a Registered Professional Geologist in the State of Alaska, USA. Mr. Morris is a fellow with the Society of Economic Geologists, a member and past officer of the Geological Society of Nevada, and a member of the Nevada Mineral Exploration Coalition.

CEO Rick Wilson states “Having worked with Alan Morris on our lithium projects, I am confident that his expertise, especially in the area of Nevada and in the field of lithium exploration, will be a great asset to Nevada Energy Metals as the company continues its aggressive project generator model.”

About Nevada Energy Metals: http://nevadaenergymetals.com/

Nevada Energy Metals Inc. is a well funded, Canadian based, exploration company who’s primary listing is on the TSX Venture Exchange. The Company’s main exploration focus is directed at lithium brine targets located in the mining friendly state of Nevada. The Company has ownership of 77 claims in Clayton Valley, only 250m from Rockwood Lithium, the only brine based lithium producer in North America (70% optioned-out to American Lithium Corp (TSX-V: Li). Nevada Energy Metals has also acquired, 100 claims (Teels Marsh West) covering 2000 acres (809 hectares) at Teels Marsh, Mineral County, Nevada, a prospective lithium exploration project, 100% owned without any royalties; the Alkali Lake Project in Esmeralda county, is a 60% earn in option agreement from Dajin Resources Corp (TSX-V: DJI), where near surface lithium values have been confirmed; On July 15, 2016 Nevada Energy Metals has agreed to an Option Agreement where LiCo Energy Metals (TSX-V:LIC) can acquire a 100% interest, subject to a 3% Net Smelter Royalty, in 348 of 911 mineral claims located in Dixie Valley, Churchill County, Nevada. Of the seven characteristics favourable for the formation of a lithium brine deposit as outlined in the U.S. Geological Survey deposit model, all seven are found in Dixie Valley. The lithium deposit model for Dixie Valley is a Clayton Valley-style brine deposit.

On Behalf of the Board of Directors

Rick Wilson, President & CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the contents of this release.

Tags: , ,
Posted in All Recent Posts, Nevada Energy Metals | Comments Off on Nevada Energy Metals Appoints Alan Morris as Geology Advisor $BFF.ca

Tetra Bio-Pharma Announces Acquisition of Intellectual Property for the Development of Natural Health Products Through Its Agro-Tek Subsidiary $TBP.ca

Posted by AGORACOM-JC at 8:35 AM on Wednesday, October 26th, 2016

Tbp_large

  • Announced that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa
  • Recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content

OTTAWA, ONTARIO–(Oct. 26, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or the “Company“) (CSE:TBP)(CSE:TBP.CN), through its subsidiary, Agro-Tek Inc. (“AGTK“), is pleased to announce that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa.

The recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content. According to the United States Food and Drug Administration (“FDA“), “FDA is not aware of any evidence that would call into question its current conclusion that cannabidiol products are excluded from the dietary supplement definition under section 201(f)(3)(B)(ii) of the Federal Food, Drug, & Cosmetics Act.”

Mr. André Rancourt, the Company’s CEO commented, “CBD or THC containing dietary supplements are currently not allowed on the USA market. However, the goal of the McGill University partnership is the development of extracts of the plant Cannabis sativa, including THC and CBD-free for the development of dietary supplements.” AGTK intends on manufacturing and commercializing supplements, food-type products and, natural health products that are compliant with Canadian and USA federal regulations. Mr. Rancourt added, “This commercial strategy involves the expertise of two of the Company’s subsidiaries, AGTK and MMP, and is in line with the Company’s vision to make AGTK and MMP leaders in the development of Cannabis sativa, derived products for the consumer market, and for the commercialization of natural supplements derived from Cannabis sativa.”

The assets acquired include proprietary formulations that have obtained marketing approval from Health Canada. The line consists of:

1. Glucose Aid; NPN 80058089

2. Kava Kava; NPN 80061986

3. Stress Ado; NPN 80065911

4. Toux Ado (Cough Ado); NPN 80065923

5. Toux enfant (Cough Children); NPN 80065928

6. Water Relax; NPN 80065948 (beverage supplement)

7. Water Cough; NPN 80066086 (beverage supplement)

8. Sleep Pro; NPN 80066679

9. Instant Relief; NPN 80066682 (topical gel for local pain relief).

The acquisition of these formulations and their proprietary ingredients will provide PhytoPain Pharma Inc. with an inventory of compounds and elements that will be used as secondary ingredients or catalysts in the formulation of our pharmaceutical grade products.

In consideration for the acquisition of the assets, the Company has issued 1,800,000 common shares to arms’ length individuals. The shares issued will be subject to a four-month hold period.

According to Mr. Rancourt, these products will allow AGTK to begin generating revenues. This is the first set of products for AGTK’s portfolio. The company will be seeking to acquire additional product lines for distribution in North America. AGTK is engaged in negotiations to acquire national distributors to expand brand identity and facilitate distribution across North America

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer

Ryan Brown
VP Business Development and Communications

Andre Audet
Executive Chairman
(613) 421-8402
[email protected]

Tags: , , ,
Posted in Medical Marijuana Stocks, Tetra Bio-Pharma Inc., Tetra Brio-Pharma Inc. | Comments Off on Tetra Bio-Pharma Announces Acquisition of Intellectual Property for the Development of Natural Health Products Through Its Agro-Tek Subsidiary $TBP.ca

Durango Provides Visits Limestone Projects Near Potential Petronas LNG Project $DGO.ca

Posted by AGORACOM-JC at 9:23 AM on Tuesday, October 25th, 2016

Logo

  • Exploration team is now in northern British Columbia at its Smith Island and Mayner’s Fortune limestone projects
  • Currently holds the past producing Smith Island limestone project located 6km southwest of Lelu Island which is where Petronas’ $36B proposed LNG facility is expected to be built

Vancouver, BC / October 25, 2016 – Durango Resources Inc. (TSX.V-DGO), (the “Company” or “Durango”) announces that further to its news of October 17th, 2016, the exploration team is now in northern British Columbia at its Smith Island and Mayner’s Fortune limestone projects.

Durango currently holds the past producing Smith Island limestone project located 6km southwest of Lelu Island which is where Petronas’ $36B proposed LNG facility is expected to be built. Durango also holds a 320-hectare property called the Mayner’s Fortune located 7.5km southwest of Terrace, B.C. which hosts six mapped sub parallel limestone units.

The Company is conducting its first phase exploration program on its limestone properties which is expected to include sampling to test for limestone quality, and mapping to confirm the historical reports. The Company is also investigating British Columbia minfile #103H 073 in the region for limestone potential. Further updates will be provided as they become available.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and certain lithium properties near the Whabouchi project, the Buckshot graphite property near the Miller Mine in Quebec, the Dianna Lake silver project in northern Saskatchewan, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario, as well as three sets of claims in the Labrador nickel corridor.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: [email protected]

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including commencement and completion of future exploration, final approval from governmental entities on the LNG project, Petronas determining whether to proceed with the LNG project and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, including market conditions, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to its prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , ,
Posted in All Recent Posts, Durango Resources | Comments Off on Durango Provides Visits Limestone Projects Near Potential Petronas LNG Project $DGO.ca

Tetra Bio-Pharma Inc. Is Increasing Its $750,000 Non-Brokered Private Placement $TBP.ca

Posted by AGORACOM-JC at 4:33 PM on Monday, October 24th, 2016

Tbp_large

  • Increasing its $750,000 non-brokered private placement (ref.: news release of October 20, 2016) to $1,000,000 for up to 6,666,667 units at a price of $0.15 per unit
  • Each unit will be consisting of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date

OTTAWA, ONTARIO–(Oct. 24, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (CSE:TBP)(CSE:TBP.UN) is increasing its $750,000 non-brokered private placement (ref.: news release of October 20, 2016) to $1,000,000 for up to 6,666,667 units at a price of $0.15 per unit. Each unit will be consisting of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date.

The private placement is expected to close no later than November 30, 2016.

The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. The Company may pay a commission in connection with the private placement, subject to compliance with the policies of the Exchange. Completion of the private placement and the payment of any commissions remain subject to the receipt of all necessary regulatory approvals, including the approval of the Exchange.

The proceeds of the private placement will be used to initiate clinical trials.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Andre Rancourt
Chief Executive Officer

Ryan Brown
VP Business Development and Communications

André Audet
Executive Chairman
[email protected]
(613) 421-8402

Tags: , ,
Posted in Medical Marijuana Stocks, Tetra Bio-Pharma Inc., Tetra Brio-Pharma Inc. | Comments Off on Tetra Bio-Pharma Inc. Is Increasing Its $750,000 Non-Brokered Private Placement $TBP.ca

Tetra Bio-Pharma Inc. Announces a $750,000 Non-Brokered Private Placement & Granting of Options $TBP.ca

Posted by AGORACOM-JC at 8:37 AM on Thursday, October 20th, 2016

Tbp_large

  • Non-brokered private placement of up to 5,000,000 units at a price of $0.15 per unit for aggregate gross proceeds of up to $750,000
  • Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date.

OTTAWA, ONTARIO–(Oct. 20, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (CSE:TBP)(CSE:TBP.CN) is conducting a non-brokered private placement of up to 5,000,000 units at a price of $0.15 per unit for aggregate gross proceeds of up to $750,000. Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date.

The private placement is expected to close no later than November 30, 2016.

The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. The Company may pay a commission in connection with the private placement, subject to compliance with the policies of the Exchange. Completion of the private placement and the payment of any commissions remain subject to the receipt of all necessary regulatory approvals, including the approval of the Exchange.

The proceeds of the private placement will be used to initiate clinical trials.

In other News:

The Company has received $341,783 in exercised warrants from September to October 2016.

The Company also announces that in accordance with the Company’s stock option plan and subject to the approval of the Canadian Securities Exchange, the Board of Directors granted an aggregate of 800,000 incentive stock options (“options”) to directors of the Company. Each option, vesting immediately upon grant, entitles the holder thereof to purchase one common share in the capital of the Company at a price of $0.18 per share until October 19, 2021. The options and any common shares issued upon exercise thereof will be subject to a four month resale restriction from the date of grant.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer
(613) 421-8402

Tetra Bio-Pharma Inc.
Ryan Brown
VP Business Development and Communications
(613) 421-8402

Tetra Bio-Pharma Inc.
Andre Audet
Executive Chairman
(613) 421-8402
[email protected]

Tags: , ,
Posted in Medical Marijuana Stocks, Tetra Bio-Pharma Inc., Tetra Brio-Pharma Inc. | Comments Off on Tetra Bio-Pharma Inc. Announces a $750,000 Non-Brokered Private Placement & Granting of Options $TBP.ca

Marijuana Company of America Q4 2016 Outlook and Update $MCOA.us

Posted by AGORACOM-JC at 8:46 AM on Tuesday, October 18th, 2016

15233_mcoa

 

  • hempSMART Brain product release imminent
  • Offers brain support and protection
  • Product is first-of-its-kind
  • Fulfillment center prepared to manage distribution of orders
  • Members signing up for PreLaunch

BONSALL, CA–(Marketwired – Oct 18, 2016) –

MARIJUANA COMPANY OF AMERICA INC., (“MCOA” or the “Company”) (OTC PINK:MCOA), an innovative cannabis and hemp marketing and distribution company, is providing this update to keep our shareholders and prospective investors informed.

Our first product, hempSMART BRAIN, formulated with CBD or Cannabidiol as the core ingredient combined with high quality, clinically proven, branded ingredients to compliment the CBD to support brain health. There are new articles published daily regarding the benefits of CBD, hempSMART BRAIN was formulated to meet the growing demand for cannabinoid based neutraceutical products that assist in brain function.

The hempSMART Brain product is scheduled for release by the end of October. It was expected to ship by the second week of October, but delays in receiving key ingredients from suppliers has pushed back the ship date by approximately two weeks. Our fulfillment center is ready to manage distribution of orders and they are working very closely with hempSMART’s manufacturer, which will result in significant efficiencies of scale.

hempSMART Brain is a first-of-its-kind product. The synergistic blend of clinically verified natural brain support ingredients, blended with water soluble CBD, enables crossing of the blood-brain barrier to provide optimal brain support and protection.

hempSMART Brain was developed to address the increase in neurologic and neurodegenerative challenges that have prompted a surge in scientific research on prevention and/or reversal of brain and nervous system pathology. A variety of natural products have been shown, in clinical trials, to improve neurological and cognitive function and there has been a surge of products being marketed to improve brain function.

Marketing leaders are currently preparing for the Brain product roll-out. The hempSMART prelaunch website: hempSMART.com is now active and accessible to the Company’s members.

According to the Direct Selling Association, in 2015 over 20 million people in the U.S. were involved in direct selling, with total sales of $36.1 billion. More than 74 percent of the American public has purchased goods or services through direct selling. Worldwide sales are also strong with more than $154 billion in sales. This marketing and distribution method is incredibly effective at creating solid sales and loyal members, as well as brand awareness in the marketplace because the sales “force” are people that passionately believe in the company, product and the difference it can make in people’s lives. The energy they can invest into the education of potential customers is far more than any other sales model.

Another key driver in the affiliate marketing industry is compensation or commission that is based on performance. Affiliate leaders earn rewards and compensation for developing training systems for their personal sales “teams” within hempSMART. Based on this win-win business model, companies can grow rapidly due to the success of the customer, the affiliate and the entire direct sales process.

Over the years, thousands of affiliate marketing teams have been established to promote new products for launch. Our affiliate marketing leaders are well established, long-term professionals. They are testing the system as well as preparing their marketing organizations for the Brain product launch. The Company has a robust affiliate marketing program that is integrated into the hempSMART.com full website which was designed and developed by ApogeeINVENT. This user-friendly platform will help our affiliates track their commissions and provide resources, and helpful information for marketing the Company’s products.

“We have received significant interest in this product and we are looking forward to updating the financial markets and our shareholders as the product release takes place,” said CEO, Donald Steinberg.

The Club Harmoneous pilot program has been extended due to regulatory challenges under the current non-profit regulatory model in California. The Company will continue to work through these challenges to develop a unique operating model that can operate under the current regulatory framework as well as the upcoming licensing and regulatory structure proposed by the Medical Marijuana Regulation and Safety Act (MMRSA). The Company is also prepared for the passing of Prop 64 in November for the adult use of marijuana in California. The Company continues to work closely with Green Dot Collective in Los Angeles County to overcome some of the regulatory challenges and changes in California. Upon satisfactory completion of the Southern California pilot program, the Company will begin expansion to Northern California and other legal adult use and medical marijuana states.

Investors are invited to visit the MCOA IR Hub on Agoracom to post questions and receive answers, or review questions and answers already posted by fellow investors. In addition, the MCOA IR HUB provides a monitored forum for investors and prospective shareholders to communicate within a clean, professional environment.
On behalf of the Board of Directors,

“Donald Steinberg”
Donald Steinberg
President & CEO
888-777-4362
MarijuanaCompanyofAmerica.com

About Marijuana Company of America, Inc.,
Marijuana Company of America (“MCOA”) is a publicly traded company headquartered in Southern California. MCOA will distribute marijuana and products related to marijuana as well as CBD and hemp, using a variety of marketing approaches to distribute on a global basis.

About hempSMART
The hempSMART brand represents MCOA’s non-THC, hemp derived, product line. All hempSMART products are formulated with a cannabinoid base that is derived from hemp and has less than a .3% THC content.

About Club Harmoneous
Club Harmoneous (The Club) delivers all of the benefits of cannabis to its members harmoneously. The Club provides a wide range of cannabis products to its members, medicinal, adult use or healthy foods, body care and cosmetics. The Club products are top-quality and offered to members at competitive prices with the convenience of home delivery.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana Company of America, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE
Marijuana Company of America Inc. will provide management services that assist legal businesses to cultivate, sell, and distribute hemp and marijuana based products within the legal guidelines of individual states and international markets. hempSMART products are derived from Hemp and contain than a .3% THC content.
For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
Harmoneous.com
agoracom.com/ir/MarijuanaCompanyofAmerica

CONTACT INFORMATION

  • Contact InformationDonald Steinberg
    President & CEO
    888-777-4362
    MarijuanaCompanyofAmerica.com

Tags: , , , , ,
Posted in Marijuana Company of America, Medical Marijuana Stocks | Comments Off on Marijuana Company of America Q4 2016 Outlook and Update $MCOA.us

« Older Entries
Newer Entries »